FTC Makes DaVita Sell Dialysis Clinics In $689M DSI Deal

Law360, New York (September 2, 2011, 6:53 PM EDT) -- The Federal Trade Commission said Friday that it will require DaVita Inc. to sell 29 outpatient dialysis clinics to resolve the agency's claims that its proposed $689 million acquisition of rival DSI Renal Inc. would be anti-competitive.

The agency filed a complaint outlining its allegations that the deal would have anti-competitive effects and a consent judgment requiring the sale of the 29 clinics to Dialysis Newco Inc., a corporation formed by venture capital firms Frazier Healthcare and New Enterprise Associates.

Denver-based DaVita entered into the deal...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.